Bio-Path Holdings Appoints New Director, Discloses Executive Compensation
Ticker: BPTH · Form: 8-K · Filed: Oct 29, 2025 · CIK: 1133818
| Field | Detail |
|---|---|
| Company | Bio-Path Holdings, Inc. (BPTH) |
| Form Type | 8-K |
| Filed Date | Oct 29, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: board-change, executive-compensation
Related Tickers: BPTH
TL;DR
BPTH adds a new director, exec comp details filed.
AI Summary
Bio-Path Holdings, Inc. announced on October 22, 2025, a change in its board of directors. Specifically, Dr. Robert L. Smith has been appointed as a new director, effective immediately. The company also disclosed compensatory arrangements for its named executive officers, though specific details of these arrangements were not provided in this excerpt.
Why It Matters
Changes in board composition can signal shifts in company strategy or governance, while executive compensation details are crucial for understanding management incentives.
Risk Assessment
Risk Level: low — This filing is a routine 8-K reporting board changes and executive compensation, with no immediate financial distress or significant operational shifts indicated.
Key Players & Entities
- Bio-Path Holdings, Inc. (company) — Registrant
- Dr. Robert L. Smith (person) — Newly appointed director
- October 22, 2025 (date) — Date of earliest event reported
FAQ
What is the effective date of Dr. Robert L. Smith's appointment as a director?
Dr. Robert L. Smith's appointment as a director is effective immediately as of October 22, 2025.
What specific compensatory arrangements were disclosed for named executive officers?
The filing indicates that compensatory arrangements of certain officers were disclosed, but the specific details of these arrangements are not provided in the provided excerpt.
What is the exact name of the registrant?
The exact name of the registrant is BIO-PATH HOLDINGS, INC.
In which jurisdiction is Bio-Path Holdings, Inc. incorporated?
Bio-Path Holdings, Inc. is incorporated in Delaware.
What is the Commission File Number for Bio-Path Holdings, Inc.?
The Commission File Number for Bio-Path Holdings, Inc. is 001-36333.
Filing Stats: 461 words · 2 min read · ~2 pages · Grade level 12.6 · Accepted 2025-10-29 11:40:48
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share BPTH N/A Indicate by ch
Filing Documents
- bpth_8k102225.htm (8-K) — 27KB
- 0001663577-25-000303.txt ( ) — 186KB
- bpth-20251022.xsd (EX-101.SCH) — 3KB
- bpth-20251022_lab.xml (EX-101.LAB) — 33KB
- bpth-20251022_pre.xml (EX-101.PRE) — 22KB
- bpth_8k102225_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this Current Report to be signed on its behalf by the undersigned hereunto duly authorized. BIO-PATH HOLDINGS, INC. Dated: October 29, 2025 By: /s/ Vikram Grover Vikram Grover Chief Executive Officer, Chief Financial Officer and Director 3